{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:34:40Z","timestamp":1791052480898,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,3]]},"DOI":"10.7759\/cureus.76840","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T09:47:47Z","timestamp":1735897667000},"source":"Crossref","is-referenced-by-count":2,"title":["Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome Associated With Celecoxib: A Case Report of a Rare Entity"],"prefix":"10.7759","author":[{"given":"Adriana","family":"Henriques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Lu\u00edsa","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jandira","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: part I. clinical perspectives","volume":"68","author":"Husain Z","year":"2013","unstructured":"Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part I. clinical perspectives. J Am Acad Dermatol. 2013, 68:693-4. 10.1016\/j.jaad.2013.01.033","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.02.072","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part I. epidemiology, pathogenesis, clinicopathological features, and prognosis","volume":"90","author":"Wei BM","year":"2024","unstructured":"Wei BM, Fox LP, Kaffenberger BH, et al.. Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part I. epidemiology, pathogenesis, clinicopathological features, and prognosis. J Am Acad Dermatol. 2024, 90:885-908. 10.1016\/j.jaad.2023.02.072","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019","volume":"68","author":"Shiohara T","year":"2019","unstructured":"Shiohara T, Mizukawa Y. Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019. Allergol Int. 2019, 68:301-8. 10.1016\/j.alit.2019.03.006","journal-title":"Allergol Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama N","year":"2022","unstructured":"Hama N, Abe R, Gibson A, Phillips EJ. Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis. J Allergy Clin Immunol Pract. 2022, 10:1155-1167.e5. 10.1016\/j.jaip.2022.02.004","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2022.100673","article-title":"DRESS syndrome: a literature review and treatment algorithm","volume":"16","author":"Calle AM","year":"2023","unstructured":"Calle AM, Aguirre N, Ardila JC, Cardona Villa R. DRESS syndrome: a literature review and treatment algorithm. World Allergy Organ J. 2023, 16:100673. 10.1016\/j.waojou.2022.100673","journal-title":"World Allergy Organ J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1270940","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management","volume":"16","author":"Shiohara T","year":"2017","unstructured":"Shiohara T, Kano Y. Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management. Expert Opin Drug Saf. 2017, 16:139-47. 10.1080\/14740338.2017.1270940","journal-title":"Expert Opin Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-03005-9","article-title":"Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review","volume":"77","author":"Sharifzadeh S","year":"2021","unstructured":"Sharifzadeh S, Mohammadpour AH, Tavanaee A, Elyasi S. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review. Eur J Clin Pharmacol. 2021, 77:275-89. 10.1007\/s00228-020-03005-9","journal-title":"Eur J Clin Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0480","article-title":"Spanish guidelines for diagnosis, management, treatment, and prevention of DRESS syndrome","volume":"30","author":"Caba\u00f1as R","year":"2020","unstructured":"Caba\u00f1as R, Ram\u00edrez E, Sendagorta E, et al.. Spanish guidelines for diagnosis, management, treatment, and prevention of DRESS syndrome. J Investig Allergol Clin Immunol. 2020, 30:229-53. 10.18176\/jiaci.0480","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun SH","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, et al.. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013, 169:1071-80. 10.1111\/bjd.12501","journal-title":"Br J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5935\/2526-5393.20230022","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a challenge in diagnosis and treatment (Article in Portuguese)","volume":"7","author":"da Costa DLC","year":"2023","unstructured":"da Costa DLC, Monteiro DM, Faria TC, De-Camargo AFF, Pereira VAR, Andrade MEB, Fernandes FR. Drug reaction with eosinophilia and systemic symptoms (DRESS): a challenge in diagnosis and treatment (Article in Portuguese). Arq Asma Alerg Imunol. 2023, 7:4-6. 10.5935\/2526-5393.20230022","journal-title":"Arq Asma Alerg Imunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22042147","article-title":"Current perspective regarding the immunopathogenesis of drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS)","volume":"22","author":"Miyagawa F","year":"2021","unstructured":"Miyagawa F, Asada H. Current perspective regarding the immunopathogenesis of drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS). Int J Mol Sci. 2021, 22:26-8. 10.3390\/ijms22042147","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/all.14032","article-title":"Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs","volume":"75","author":"Do\u00f1a I","year":"2020","unstructured":"Do\u00f1a I, P\u00e9rez-S\u00e1nchez N, Eguiluz-Gracia I, Mu\u00f1oz-Cano R, Bartra J, Torres MJ, Cornejo-Garc\u00eda JA. Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. Allergy. 2020, 75:561-75. 10.1111\/all.14032","journal-title":"Allergy"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.113598","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs): A current insight into its molecular mechanism eliciting organ toxicities","volume":"172","author":"Panchal NK","year":"2023","unstructured":"Panchal NK, Prince Sabina E. Non-steroidal anti-inflammatory drugs (NSAIDs): A current insight into its molecular mechanism eliciting organ toxicities. Food Chem Toxicol. 2023, 172:113598. 10.1016\/j.fct.2022.113598","journal-title":"Food Chem Toxicol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2008.23.3.521","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs","volume":"23","author":"Lee JH","year":"2008","unstructured":"Lee JH, Park HK, Heo J, et al.. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs. J Korean Med Sci. 2008, 23:521-5. 10.3346\/jkms.2008.23.3.521","journal-title":"J Korean Med Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-03389-z","article-title":"Demystifying drug reaction with eosinophilia and systemic symptoms (DRESS): a review of the literature and guidelines for management","volume":"316","author":"Wedel CL","year":"2024","unstructured":"Wedel CL. Demystifying drug reaction with eosinophilia and systemic symptoms (DRESS): a review of the literature and guidelines for management. Arch Dermatol Res. 2024, 316:644. 10.1007\/s00403-024-03389-z","journal-title":"Arch Dermatol Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.02.073","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management","volume":"90","author":"Wei BM","year":"2024","unstructured":"Wei BM, Fox LP, Kaffenberger BH, et al.. Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management. J Am Acad Dermatol. 2024, 90:911-26. 10.1016\/j.jaad.2023.02.073","journal-title":"J Am Acad Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6928363","article-title":"Immunohistopathological findings of severe cutaneous adverse drug reactions","volume":"2017","author":"Orime M","year":"2017","unstructured":"Orime M. Immunohistopathological findings of severe cutaneous adverse drug reactions. J Immunol Res. 2017, 2017:6928363. 10.1155\/2017\/6928363","journal-title":"J Immunol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/327633-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-syndrome-associated-with-celecoxib-a-case-report-of-a-rare-entity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T09:47:50Z","timestamp":1735897670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/327633-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-syndrome-associated-with-celecoxib-a-case-report-of-a-rare-entity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.76840","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,3]]}}}